ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Q&A: Data that Killed CYP2D6 Testing Contradict Fundamental Law of Nature

May 18, 2012

Translational Research Needs Coordination, Budget, Advisors Say. Former SWOG Chairman Hoogstraten Publishes Memoir.

June 23, 2006

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996

In Brief: Cancer Control Funds For Clinical Trials Intended To Upgrade Quality of Care: Terry

January 16, 1981

Tobacco Council Grants Total 3,348

July 15, 1988

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002